ESC 365 - Cardiac radioablation does not worsen cardiac function: preliminary safety results of the prospective STARNL-1 trial

ESC Professional Premium Access

Cardiac radioablation does not worsen cardiac function: preliminary safety results of the prospective STARNL-1 trial

Session: From diagnostic evaluation to new treatment options for patients with ventricular arrhythmias

Topic: Radiotherapy

Speaker: Mr W. Hoeksema (Amsterdam, NL)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mr Wiert Hoeksema

Amsterdam (Netherlands (The))

0 follower

7 more presentations in this session

Diagnostic value of electroanatomical mapping in patients with suspected arrhythmogenic cardiomyopathy

Speaker: Mr A. Villatore (Milan, IT)

Correlations between endocardial voltage mapping, diagnosis and genetic in patients with arrhythmogenic right ventricular cardiomyopathy

Speaker: Doctor P. Maury (Toulouse, FR)

Prediction of programmed ventricular stimulation inducibility using machine learning in post-myocardial infarction patients at risk for sudden cardiac arrest with preserved ejection fraction >=40%

Speaker: Doctor A. Xintarakou (Athens, GR)

Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden cardiac death

Speaker: Doctor G. Lopes da Cunha (Lisbon, PT)

Risk factors for the development of premature ventricular complex-induced cardiomyopathy: a systematic review and meta-analysis

Speaker: Mr T. Serban (Basel, CH)

Access the full session

From diagnostic evaluation to new treatment options for patients with ventricular arrhythmias

Speakers: Mr W. Hoeksema, Mr A. Villatore, Doctor P. Maury, Doctor A. Xintarakou, Doctor G. Lopes da Cunha...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources